Article Details
Retrieved on: 2021-05-10 14:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
TellBio's TellDx technology allows for the isolation of CTCs in liquid biopsies, regardless of cancer type. The company's TellRx platform leverages ...
Article found on: www.utahbusiness.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here